| Price | $73.45 |
| Year Range | $59.58 – $87.26 |
| Market Cap | $10.6B |
| Industry | Biotechnology |
What Is Cytokinetics’s AI Stock Analysis?
Cytokinetics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Cytokinetics’s momentum in near-real time.
Cytokinetics (CYTK) has an AltIndex AI Score of 30/100, currently a Strong Sell signal. The AI Score distills Cytokinetics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Cytokinetics’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Cytokinetics — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving CYTK’s AI Score?
Fundamentals
Revenue for the last quarter was $19M. This is an increase of 9.01% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 1,125.78%, suggesting positive year-over-year growth. Net income for the last quarter was $-206M. This represents a decrease of 12.57% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 27.67%, which may be a cause for concern. Ebitda for the last quarter was $-184M. This represents a decrease of 1.81% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 34.88%, which may be a cause for concern. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.
See Cytokinetics’s earnings and insider transactions.
Technicals
Today's stock price is $73.45. This represents a decrease of 10.69% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 89.70%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $77.18, which is lower than the previous SMA10 of $77.55. This suggests a potential downward trend in price movement. The RSI is 39.2, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Cytokinetics has an estimated 44 open positions. This number is up by 10% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Cytokinetics is low (an estimate of only 39% of employees have a positive outlook), a concerning sign. Cytokinetics has an estimate of 42,000 visitors to their webpage. The number of visitors is down by -71% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Cytokinetics’s job postings, web traffic and app downloads.
Sentiment & social
However, the sentiment is down by -14% in the last couple of weeks, a worrisome trend. Cytokinetics has 1,900 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track Cytokinetics’s market sentiment.
Frequently Asked Questions: Cytokinetics AI Stock Analysis
Cytokinetics's AltIndex AI Score is 30/100, currently a Strong Sell signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Cytokinetics a Strong Sell (30/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Cytokinetics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the CYTK AI Score or sign up to read the full thesis.
